CS-101 in Patients With β-thalassemia
CS-101 in Patients With β-thalassemia
Enrolling by invitation · NCT06328764 · Registry updated 2026-06-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| CS-101 in Patients With β-thalassemia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, anemia, beta thalassemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, thalassemia | Enrolling by invitation | Early phase 1 | 2026-06-09 | NCT06328764 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| CorrectSequence Therapeutics Co., Ltd | 8 |
| First Affiliated Hospital of Guangxi Medical University | 96 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The First Affiliated Hospital of Guangxi Medical University | Nanning | China | 33 |